Regulatory/Legislation

A Brief Regulatory History of Process Validation

September 25, 2018

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsernamePassword Remember Me  

Prepare for Recalls: 5 Crucial Steps

August 6, 2018

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsernamePassword Remember Me  

Crystal Ball: 2018 Federal Election

June 29, 2018

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsernamePassword Remember Me  

AAHP Rouses 38,000 Letters to Capitol Hill and Garners Congressional Support

June 4, 2018

As the result of the AAHP’s first grassroots effort, 38,000 letters from consumers and health care providers poured into offices of U.S. senators and representatives this spring. The letter-writing campaign urged Congressional leaders to ask the U.S. Food and Drug Administration (FDA) to incorporate key elements of the 1988 guidance regulating homeopathic products into the newly proposed…

How Much Can Machine Learning Help Us?

June 4, 2018

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsernamePassword Remember Me  

AAHP Speaking Tour

April 24, 2018

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsernamePassword Remember Me  

Legislative Update: Actions Since FDA’s Draft Guidance

March 7, 2018

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsernamePassword Remember Me  

United States Food and Drug Administration – Good Guidance Practices

January 30, 2018

This content is restricted to AAHP members. If you are a member, please login. If you are not a member, click here.Existing Users Log InUsernamePassword Remember Me  

Steps Toward Building Grassroots Support

December 6, 2017

December 6, 2017 Since the FDA hearing and the FTC workshop in 2015, the homeopathic industry has received more attention than usual from regulators. While AAHP continually meets with congressional leaders in Washington and works with both agencies, your association is also working to mobilize stakeholders. It’s important for legislators to hear a cry of…

Recall Preparedness

November 20, 2017

By Mark Land, AAHP president November 20, 2017 Risks associated with the therapeutic use of healthcare products are real. Manufacturers and the U.S. Food and Drug Administration (FDA) balance these risks all of the time when making marketing authorization decisions. These risks can be evaluable or unanticipated. Evaluable risks from the direct chemical, physical, or…

AAHP monitors and reports on current federal regulations, legislation and government policies that affect the homeopathic community. AAHP is often the first to learn of regulatory changes that have both direct and indirect effects on our industry enabling members to stay ahead of the curve in a rapidly changing healthcare environment.

Leave a Comment

You must be logged in to post a comment.